FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1503189223> ?p ?o ?g. }

• W1503189223 endingPage "655" @default.
• W1503189223 startingPage "648" @default.
• W1503189223 abstract "BACKGROUND: Lower alimentary tract mucositis is a serious complication of chemotherapy. The aim of the study was to determine the incidence, risk factors, and mortality of lower alimentary tract mucositis in a homogeneous population of patients with newly diagnosed myeloma receiving similar antineoplastic therapy and standardized supportive care. METHODS: Lower alimentary tract mucositis was evaluated among 303 consecutive patients with myeloma (2004-2007) enrolled in a clinical trial consisting of induction chemotherapy, tandem melphalan-based autologous stem cell transplantation (ASCT), and consolidation. Lower alimentary tract mucositis was defined as neutropenia-associated grade II-IV enteritis/colitis. Pretreatment risk factors were examined including body surface area (BSA), serum albumin (albumin), and estimated creatinine clearance (CrCl). Multiple logistic regression model was used to compute adjusted odds ratio (OR) and 95% confidence intervals (CI). RESULTS: Forty-seven (15.5%) patients developed lower alimentary tract mucositis during 1529 courses of chemotherapy (including 536 melphalan-based ASCT). Pre-enrollment BSA <2 m2 (OR, 2.768; 95% CI, 1.200-6.381; P = .0169) increased the risk for lower alimentary tract mucositis, whereas higher albumin was protective (OR, 0.698; 95% CI, 0.519-0.940; P = .0177). Pretransplant variables associated with lower alimentary tract mucositis were BSA <2 m2 (OR, 4.451; 95% CI, 1.459-13.58, P = .0087) and estimated CrCl <60 mL/min (OR, 3.493; 95% CI, 1.173-10.40; P = .0246). Higher albumin level conferred protection (OR, 0.500; 95% CI, 0.304-0.820; P = .0061). No lower alimentary tract mucositis-related death was observed. CONCLUSIONS: Lower alimentary tract mucositis is not uncommon among a homogenous population of oncology patients undergoing sequential courses of chemotherapy including melphalan-based ASCT but does not contribute to mortality. Lower BSA, renal function, and albumin are associated with increased risk for lower alimentary tract mucositis. Cancer 2011. © 2010 American Cancer Society." @default.
• W1503189223 created "2016-06-24" @default.
• W1503189223 creator A5000879635 @default.
• W1503189223 creator A5005449102 @default.
• W1503189223 creator A5007152490 @default.
• W1503189223 creator A5052077997 @default.
• W1503189223 creator A5069739901 @default.
• W1503189223 creator A5070347191 @default.
• W1503189223 date "2010-09-22" @default.
• W1503189223 modified "2023-10-18" @default.
• W1503189223 title "Incidence and risk factors for lower alimentary tract mucositis after 1529 courses of chemotherapy in a homogenous population of oncology patients" @default.
• W1503189223 cites W103788795 @default.
• W1503189223 cites W1853332726 @default.
• W1503189223 cites W1857706035 @default.
• W1503189223 cites W1978720709 @default.
• W1503189223 cites W1981257484 @default.
• W1503189223 cites W1985482871 @default.
• W1503189223 cites W2011330820 @default.
• W1503189223 cites W2011871138 @default.
• W1503189223 cites W2016059561 @default.
• W1503189223 cites W2017795828 @default.
• W1503189223 cites W2018768214 @default.
• W1503189223 cites W2025371458 @default.
• W1503189223 cites W2030986513 @default.
• W1503189223 cites W2033046938 @default.
• W1503189223 cites W2033816900 @default.
• W1503189223 cites W2034106072 @default.
• W1503189223 cites W2057230334 @default.
• W1503189223 cites W2057552045 @default.
• W1503189223 cites W2071342876 @default.
• W1503189223 cites W2079836113 @default.
• W1503189223 cites W2082134267 @default.
• W1503189223 cites W2088900329 @default.
• W1503189223 cites W2091178007 @default.
• W1503189223 cites W2121288264 @default.
• W1503189223 cites W2128029799 @default.
• W1503189223 cites W2135455274 @default.
• W1503189223 cites W2136652338 @default.
• W1503189223 cites W2138000143 @default.
• W1503189223 cites W2140622992 @default.
• W1503189223 cites W2147787450 @default.
• W1503189223 cites W2155742443 @default.
• W1503189223 cites W2156546371 @default.
• W1503189223 cites W2160115655 @default.
• W1503189223 cites W2316160054 @default.
• W1503189223 cites W4229493097 @default.
• W1503189223 cites W4246055077 @default.
• W1503189223 cites W6717101 @default.
• W1503189223 doi "https://doi.org/10.1002/cncr.25633" @default.
• W1503189223 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20862749" @default.
• W1503189223 hasPublicationYear "2010" @default.
• W1503189223 type Work @default.
• W1503189223 sameAs 1503189223 @default.
• W1503189223 citedByCount "25" @default.
• W1503189223 countsByYear W15031892232012 @default.
• W1503189223 countsByYear W15031892232013 @default.
• W1503189223 countsByYear W15031892232014 @default.
• W1503189223 countsByYear W15031892232015 @default.
• W1503189223 countsByYear W15031892232016 @default.
• W1503189223 countsByYear W15031892232017 @default.
• W1503189223 countsByYear W15031892232018 @default.
• W1503189223 countsByYear W15031892232019 @default.
• W1503189223 countsByYear W15031892232020 @default.
• W1503189223 countsByYear W15031892232021 @default.
• W1503189223 countsByYear W15031892232022 @default.
• W1503189223 countsByYear W15031892232023 @default.
• W1503189223 crossrefType "journal-article" @default.
• W1503189223 hasAuthorship W1503189223A5000879635 @default.
• W1503189223 hasAuthorship W1503189223A5005449102 @default.
• W1503189223 hasAuthorship W1503189223A5007152490 @default.
• W1503189223 hasAuthorship W1503189223A5052077997 @default.
• W1503189223 hasAuthorship W1503189223A5069739901 @default.
• W1503189223 hasAuthorship W1503189223A5070347191 @default.
• W1503189223 hasBestOaLocation W15031892231 @default.
• W1503189223 hasConcept C126322002 @default.
• W1503189223 hasConcept C141071460 @default.
• W1503189223 hasConcept C2776364478 @default.
• W1503189223 hasConcept C2776694085 @default.
• W1503189223 hasConcept C2778496288 @default.
• W1503189223 hasConcept C2778684742 @default.
• W1503189223 hasConcept C2908647359 @default.
• W1503189223 hasConcept C2911091166 @default.
• W1503189223 hasConcept C71924100 @default.
• W1503189223 hasConcept C90924648 @default.
• W1503189223 hasConcept C99454951 @default.
• W1503189223 hasConceptScore W1503189223C126322002 @default.
• W1503189223 hasConceptScore W1503189223C141071460 @default.
• W1503189223 hasConceptScore W1503189223C2776364478 @default.
• W1503189223 hasConceptScore W1503189223C2776694085 @default.
• W1503189223 hasConceptScore W1503189223C2778496288 @default.
• W1503189223 hasConceptScore W1503189223C2778684742 @default.
• W1503189223 hasConceptScore W1503189223C2908647359 @default.
• W1503189223 hasConceptScore W1503189223C2911091166 @default.
• W1503189223 hasConceptScore W1503189223C71924100 @default.
• W1503189223 hasConceptScore W1503189223C90924648 @default.
• W1503189223 hasConceptScore W1503189223C99454951 @default.
• W1503189223 hasIssue "3" @default.
• W1503189223 hasLocation W15031892231 @default.

• next